Related Experiment Video
Updated: May 5, 2026

Assessment of Knee Hyperalgesia in Mice using Pressure Application Measurement
Published on: June 13, 2025
How analgesia-sedation alters monocyte mCD14 and HLA-DR levels in patients undergoing cerebral angiography?
Sibel Akyol1, Ercan Tureci, Taner Tanriverdi
1Istanbul University, Cerrahpasa Medical Faculty, Department of Physiology, Istanbul, Turkey.
Insights
Analgesia-sedation significantly impacts immune cells like T lymphocytes during cerebral angiography. This suggests a need for tailored anesthetic approaches based on patient immunology to mitigate immune suppression.
Area of Science:
- Immunology
- Neuroscience
- Anesthesiology
Background:
- Cerebral angiography procedures carry risks that may be influenced by patient immune status.
- Understanding the immunomodulatory effects of analgesia-sedation is crucial for patient management.
Purpose of the Study:
- To investigate the impact of analgesia-sedation on Human Leukocyte Antigen - antigen D Related (HLA-DR) and cytokine levels (IL-10, IL-6) in patients undergoing cerebral angiography.
- To assess changes in immune cell populations following cerebral angiography with and without analgesia-sedation.
Main Methods:
- A cohort of 41 male patients undergoing cerebral angiography was studied.
- Patients were divided into two groups: one receiving analgesia-sedation (Group II, n=34) and a control group (Group I, n=7).
- Venous blood samples were collected pre- and post-procedure for immunological analysis.
Main Results:
- Analgesia-sedation led to a significant increase in CD4+ and CD19+ T lymphocytes (p < 0.001).
- The control group (no analgesia-sedation) exhibited a significant increase in CD40, CD154, and MHC-II levels (p < 0.001) post-procedure.
- Fentanyl and midazolam's effects on immune response appear linked to monocyte and mHLA-DR expression.
Conclusions:
- Analgesia-sedation, specifically fentanyl and midazolam, influences immune responses, potentially via monocyte and mHLA-DR expression.
- Future anesthetic strategies should consider individual patient immunological status.
- Development of anesthetic agents that minimize immune suppression is warranted for patients undergoing cerebral angiography.
Aim:
This study aims to evaluate how analgesia-sedation causes alterations of HLA-DR and cytokines (IL-10 and IL-6) in patients undergoing cerebral angiography for several cerebral vascular diseases.
Material And Methods:
This study includes 41 males who underwent cerebral angiography. The study sample was divided into two: Group I had 7 patients who did not receive and group II had 34 patients who received analgesia-sedation before cerebral angiography. A venous blood sample was collected before and after cerebral angiography.
Results:
Analgesia-sedation caused significant increase CD4+ and CD19 T lymphocytes (p < 0.001) but group I showed significant increase in CD40, CD154, and MHC-II levels (p < 0.001) after cerebral angiography.
Conclusion:
We suggest that the effects of fentanyl and midazolam on the immune response are the reflection of the effects by the monocyte, mHLA-DR expression. In the future, depending on the immunological status of the patients, different anesthetic applications including the new anesthetic agents that will be able to decrease immune system suppression will be required.
More Related Videos
04:32Measuring Post-Stroke Cerebral Edema, Infarct Zone and Blood-Brain Barrier Breakdown in a Single Set of Rodent Brain Samples
Published on: October 23, 2020
08:41Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice
Published on: December 29, 2016
Related Concept Videos
Stages of General Anesthesia
Analgesia and Pain Management
Local Anesthetics: Clinical Application as Spinal Anesthesia